Humacyte, Inc. Common Stock
HUMA Real Time Price USDRecent trades of HUMA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by HUMA's directors and management
Government lobbying spending instances
-
$10,000 Oct 21, 2024 Issue: Budget/Appropriations
-
$10,000 Oct 14, 2024 Issue: Health Issues
-
$10,000 Jul 19, 2024 Issue: Health Issues
-
$10,000 Apr 18, 2024 Issue: Health Issues
-
$10,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jan 21, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2020 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2020 Issue: Medicare/Medicaid
-
$50,000 Apr 24, 2020 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2020 Issue: Medicare/Medicaid
-
$50,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$50,000 Jul 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Jan 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Oct 22, 2018 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2018 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2018 Issue: Medicare/Medicaid
-
$50,000 Jan 22, 2018 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2017 Issue: Medicare/Medicaid
-
$20,000 Jul 20, 2017 Issue: Medicare/Medicaid
-
$30,000 Jul 20, 2017 Issue: Medicare/Medicaid
-
$40,000 Apr 20, 2017 Issue: Medicare/Medicaid
-
$40,000 Jan 23, 2017 Issue: Medicare/Medicaid
-
$40,000 Oct 20, 2016 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2016 Issue: Medicare/Medicaid
-
$40,000 Apr 20, 2016 Issue: Medicare/Medicaid
-
$40,000 Jan 19, 2016 Issue: Medicare/Medicaid
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: System, apparatuses, devices and methods for straining a cultivated tissue Oct. 01, 2024
-
Patent Title: Fluid systems, apparatuses, devices and methods of management thereof for cultivating tissue Apr. 16, 2024
-
Patent Title: Tubular prostheses Jul. 13, 2021
-
Patent Title: Tissue-engineered constructs Mar. 16, 2021
-
Patent Title: Tissue-engineered constructs Mar. 02, 2021
-
Patent Title: Methods and apparatuses for forming fibrous tubes Jul. 30, 2019
-
Patent Title: Tubular prostheses Jan. 08, 2019
-
Patent Title: Tubular tissue-engineered constructs May. 23, 2017
-
Patent Title: Tissue-engineered constructs May. 16, 2017
-
Patent Title: Tissue-engineered constructs Jan. 31, 2017
-
Patent Title: Compositions and methods for soft tissue augmentation Jun. 12, 2012
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of HUMA in WallStreetBets Daily Discussion
Recent insights relating to HUMA
Recent picks made for HUMA stock on CNBC
ETFs with the largest estimated holdings in HUMA
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view HUMA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.